NCT06574698
- Conditions
- GD2 Antibody (Naxitamab), Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Guangzhou Women And Children's Medical Center Guanzhou, Guangdong, China
Clinical trial condition
GD2 Antibody (Naxitamab)
Explore clinical trials studying GD2 Antibody (Naxitamab). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study